A clinical trial to evaluate the efficacy and safety precisely unveiled the comparative effectiveness of Sadangpaniya-phanta,Vayasathapana-kasya ghana tablet and Viyoshadi churna tablet in the treatment of COVID-19
- Conditions
- Other specified viral diseases. Ayurveda Condition: Covid-19, (2) ICD-10 Condition: B338||Other specified viral diseases,
- Registration Number
- CTRI/2021/08/035468
- Lead Sponsor
- Dr Rajesh Adhana
- Brief Summary
Present study is a Randomized open label controlled pragmatic trial to evaluate the efficacy and safety of sadangpaniya phant, vayasthapana-kasay ghana tablet and viyosadi churana tablet in the treatment of Covid-19 virus infection -A deadly diseases. Epidemic is sweeping through the worldwide instantly. Billions of people lost their lives all over the world due to this single stranded RNA virus SARS-COV-2. there is no clinical interventions are being done worldwide .Consequently , it is necessary to draw on pluralistic knowledge system available globally. Combination of above mentioned three drugs are classical AYURVEDIC REMEDIES which will clinically investigated in mild case of Covid-!9 patient. As majority (80%) of Covid-19 cases present with mild symptom (cough,fever, diarrhoea, dyspnea, weakness).It is double arm comparative study with conventional interventions. Assessment will be done on parameters as time to wane the symptoms and diseases not to deteriorate, duration of hospitalization etc.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 70
Patient with mild symptoms of covid-19( Rapid test and RT-PCR) positive case will be enrolled.
Patient with moderate and sever Covid-19 infection having Pneumonia, Pregnant female patient with covid-19 infection will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical recovery will be defined as sustained alleviation of illness based on symptom scores fever,cough,diarrhea,myalgia,dyspnea,all being absent. 10 days
- Secondary Outcome Measures
Name Time Method Symptomatic recovery as cough fever with on SpO2 decline greater than3% and respiratory rate more than 30 per minute and no feeling of weakness and no insomnia 28 days
Trial Locations
- Locations (1)
Uttrakhand Ayurved University
🇮🇳Dehradun, UTTARANCHAL, India
Uttrakhand Ayurved University🇮🇳Dehradun, UTTARANCHAL, IndiaDr Rajesh AdhanaPrincipal investigator9412956506vaidadhanarajesh@gmail.com